USPTO serial 79216397
Serial No. 79216397
Reviewed by CopyMark Law Group
Reg. 5516148Status 709
- Filing date
- Status date
- Registration date
- Jul 17, 2018
- Examiner
- BEVERLY, JOSETTE MICHELLE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79216397?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Simone Chen
Simone Chen MUNCY, GEISSLER, OLDS & LOWE, P.C.4000 Legato Road, Suite 310Fairfax, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for the treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; dietetic foods adapted for medical purposes; air purifying preparations; biological preparations for veterinary purposes for the treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; vermin destroying preparations; biomedicine for the treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; prepared Chinese medicine for the treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; raw material medicine for the treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; pharmaceutical preparations in the form of injection for the treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; pharmaceutical preparations in the form of tablet for the treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease | SECTION 71 - CANCELLED | — |
| 042 | Technical project studies, namely, technical project planning and design engineering of lines for the processing of pharmaceutical products; research and development of new products for others; chemical analysis; chemical research; bacteriological research; biological research | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 23, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 23, 2026 | INPC | INVALIDATION PROCESSED | — |
| Sep 30, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 31, 2025 | C71T | CANCELLED SECTION 71 | — |
| Jul 17, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 16, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 29, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 29, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 17, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 17, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 1, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 1, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 11, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 12, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 15, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 15, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 7, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 21, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 29, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 29, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 28, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 27, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |